Therefore, ERK1/2 is highly expressed in the region with dead cells, which is further confirmed by the use of ERK1/2 inhibitor U0126 that effectively inhibited the inflammatory response induced by cerebral ischemia and reduced cell injury (20, 21). The gene discussed is MAPK3; the disease is brain ischemia.